Skip to main content
. 2023 May 17;6(5):e2312625. doi: 10.1001/jamanetworkopen.2023.12625

Figure 3. Subgroup Analyses of Overall Survival (OS) and Progression-Free Survival (PFS) in the Intention-to-Treat Population.

Figure 3.

BMI indicates body mass index (calculated as weight in kilograms divided by height in meters squared); CRTCT, simultaneous integrated boost radiotherapy with concurrent and consolidated oral S-1 chemotherapy; ECOG PS, Eastern Cooperative Oncology Group performance score; HR, hazard ratio; RT, simultaneous integrated boost radiotherapy alone.